Abstract
239 Efficacy of peripheral deposition of inhaled rhDNase in CF patients during a respiratory tract exacerbation E.M. Bakker1, S. Volpi2, E. Salonini2, B. Mullinger3, P. Kroneberg3, W.C.J. Hop4, B.M. Assael2, H.A.W.M. Tiddens1,5. 1Erasmus MC − Sophia Children’s Hospital, Pediatric Pulmonology, Rotterdam, Netherlands; 2Azienda Ospedaliera di Verona, Cystic Fibrosis Centre, Verona, Italy; 3Activaero GmbH, Gemunden, Germany; 4Erasmus MC − Sophia Children’s Hospital, Epidemiology and Biostatistics, Rotterdam, Netherlands; 5Erasmus MC, Radiology, Rotterdam, Netherlands
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
